Takeda Biopharmaceuticals India Private Limited, a global biopharmaceutical leader, showcased its cutting-edge digital innovations at the G20 Health Working Group meeting in Goa, India, from April 17th to April 19th. Takeda’s digital health solutions were presented in line with the G20 meeting’s focus on “Citizen-Centric Health Delivery Ecosystems for Universal Health Coverage leveraging Digital Health and Innovations.” Discussions centered on creating a digital health ecosystem, innovations in healthcare, technology aiding continuing care, and digital public health goods. Attendees included representatives of G20 member countries, special invitee countries, and relevant international organizations.
Three innovative solutions were presented at the event, including MyPKFit, Synapse, and Athena. MyPKFit is an FDA-approved application that offers personalized and interactive prophylaxis treatment options. The application allows both healthcare professionals and patients to monitor factor VIII levels in real-time on smartphones, enabling them to make activity decisions accordingly and improve their quality of life. Synapse is a valuable platform designed to enhance awareness and knowledge-sharing among healthcare professionals. The platform has successfully engaged over 4000 healthcare professionals through scientific exchange and educational initiatives, leading to significant positive impact on many lives. The Athena App MVP leverages a smartphone app integrated with consumer wearables and empowers patients to easily track, understand, and communicate simple, robust measures of Quality of Life (QOL).
Digital innovations have transformed virtually every aspect of our lives, and healthcare is no exception. Ruchi Sogarwal, Head of Corporate Affairs, Takeda Biopharmaceutical India Pvt Ltd, emphasized the significance of digital innovations in healthcare, stating, “The potential benefits of these innovations are enormous, including improved patient outcomes, increased access to care, and more efficient healthcare delivery. Our participation in the G20 Health Working Group meeting provided a platform to showcase our capabilities and explore potential collaborations with G20 member countries.”
At Takeda, they are committed to leveraging digital solutions to transform healthcare. Puneet Chopra, Head – Data, Digital and Technology, Takeda Biopharmaceutical India Pvt Ltd, said, “Our innovative solutions, MyPKFit, Synapse, and Athena, are aimed at improving patient outcomes and advancing healthcare access. We are excited to have showcased our digital capabilities at the G20 meeting and explore opportunities to collaborate with stakeholders to drive digital health innovation and adoption.”
Takeda Biopharmaceuticals’ participation in the G20 Health Working Group meeting provided an opportunity to showcase its digital innovations and explore potential collaborations with stakeholders to drive digital health innovation and adoption. As the world continues to recuperate from a global pandemic, a collaborative effort to address every unmet health concern becomes a priority. Through their digital innovations, Takeda Biopharmaceuticals is committed to transforming healthcare and empowering healthcare professionals with the knowledge and tools necessary to make a positive impact on patients’ lives.